Cibc World Markets Corp Esperion Therapeutics, Inc. Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 24,604 shares of ESPR stock, worth $70,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,604
Previous 41,928
41.32%
Holding current value
$70,859
Previous $60,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ESPR
# of Institutions
185Shares Held
109MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$40.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$33.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$29.8 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$28.7 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.2 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $192M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...